Literature DB >> 27713027

The secretome of Acinetobacter baumannii ATCC 17978 type II secretion system reveals a novel plasmid encoded phospholipase that could be implicated in lung colonization.

Noha M Elhosseiny1, Ossama M El-Tayeb2, Aymen S Yassin2, Stephen Lory3, Ahmed S Attia4.   

Abstract

Acinetobacter baumannii infections are compounded with a striking lack of treatment options. In many Gram-negative bacteria, secreted proteins play an important early role in avoiding host defences. Typically, these proteins are targeted to the external environment or into host cells using dedicated transport systems. Despite the fact that medically relevant species of Acinetobacter possess a type II secretion system (T2SS), only recently, its significance as an important pathway for delivering virulence factors has gained attention. Using in silico analysis to characterize the genetic determinants of the T2SS, which are found clustered in other organisms, in Acinetobacter species, they appear to have a unique genetic organization and are distributed throughout the genome. When compared to other T2SS orthologs, individual components of the T2SS apparatus showed the highest similarity to those of Pseudomonas aeruginosa. A mutant of Acinetobacter baumannii strain ATCC 17978 lacking the secretin component of the T2SS (ΔgspD), together with a trans-complemented mutant, were tested in a series of in vitro and in vivo assays to determine the role of T2SS in pathogenicity. The ΔgspD mutant displayed decreased lipolytic activity, associated with attenuated colonization ability in a murine pneumonia model. These phenotypes are linked to LipAN, a novel plasmid-encoded phospholipase, identified through mass spectroscopy as a T2SS substrate. Recombinant LipAN showed specific phospholipase activity in vitro. Proteomics on the T2-dependent secretome of ATCC 17978 strain revealed its potential dedication to the secretion of a number of lipolytic enzymes, among others which could contribute to its virulence. This study highlights the role of T2SS as an active contributor to the virulence of A. baumannii potentially through secretion of a newly identified phospholipase. Copyright Â
© 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  A. baumannii; Phospholipase; T2SS; Virulence

Mesh:

Substances:

Year:  2016        PMID: 27713027     DOI: 10.1016/j.ijmm.2016.09.006

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  10 in total

Review 1.  Expanding Role of Type II Secretion in Bacterial Pathogenesis and Beyond.

Authors:  Nicholas P Cianciotto; Richard C White
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

2.  The structure of Acinetobacter-secreted protease CpaA complexed with its chaperone CpaB reveals a novel mode of a T2SS chaperone-substrate interaction.

Authors:  Darya V Urusova; Rachel L Kinsella; Nichole D Salinas; M Florencia Haurat; Mario F Feldman; Niraj H Tolia
Journal:  J Biol Chem       Date:  2019-07-18       Impact factor: 5.157

3.  InvL, an Invasin-Like Adhesin, Is a Type II Secretion System Substrate Required for Acinetobacter baumannii Uropathogenesis.

Authors:  Clay D Jackson-Litteken; Gisela Di Venanzio; Nguyen-Hung Le; Nichollas E Scott; Bardya Djahanschiri; Jesus S Distel; Evan J Pardue; Ingo Ebersberger; Mario F Feldman
Journal:  mBio       Date:  2022-05-31       Impact factor: 7.786

4.  Comparative genomic analysis of Acinetobacter strains isolated from murine colonic crypts.

Authors:  Azadeh Saffarian; Marie Touchon; Céline Mulet; Régis Tournebize; Virginie Passet; Sylvain Brisse; Eduardo P C Rocha; Philippe J Sansonetti; Thierry Pédron
Journal:  BMC Genomics       Date:  2017-07-11       Impact factor: 3.969

Review 5.  Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.

Authors:  Chang-Ro Lee; Jung Hun Lee; Moonhee Park; Kwang Seung Park; Il Kwon Bae; Young Bae Kim; Chang-Jun Cha; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Cell Infect Microbiol       Date:  2017-03-13       Impact factor: 5.293

6.  CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII.

Authors:  Ursula Waack; Mark Warnock; Andrew Yee; Zachary Huttinger; Sara Smith; Ayush Kumar; Alban Deroux; David Ginsburg; Harry L T Mobley; Daniel A Lawrence; Maria Sandkvist
Journal:  mBio       Date:  2018-12-18       Impact factor: 7.867

7.  Evolution of Acinetobacter baumannii in Clinical Bacteremia Patients.

Authors:  Henan Li; Jiangang Zhang; Zhiren Wang; Yuyao Yin; Hua Gao; Ruobing Wang; Longyang Jin; Qi Wang; Chunjiang Zhao; Zhanwei Wang; Hui Wang
Journal:  Infect Drug Resist       Date:  2021-08-31       Impact factor: 4.003

8.  Targeting the Type II Secretion System: Development, Optimization, and Validation of a High-Throughput Screen for the Identification of Small Molecule Inhibitors.

Authors:  Ursula Waack; Tanya L Johnson; Khalil Chedid; Chuanwu Xi; Lyle A Simmons; Harry L T Mobley; Maria Sandkvist
Journal:  Front Cell Infect Microbiol       Date:  2017-08-28       Impact factor: 5.293

Review 9.  Acinetobacter: an emerging pathogen with a versatile secretome.

Authors:  Noha M Elhosseiny; Ahmed S Attia
Journal:  Emerg Microbes Infect       Date:  2018-03-21       Impact factor: 7.163

10.  The Glycoprotease CpaA Secreted by Medically Relevant Acinetobacter Species Targets Multiple O-Linked Host Glycoproteins.

Authors:  M Florencia Haurat; Nichollas E Scott; Gisela Di Venanzio; Juvenal Lopez; Benjamin Pluvinage; Alisdair B Boraston; Michael J Ferracane; Mario F Feldman
Journal:  mBio       Date:  2020-10-06       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.